Verge Genomics Company
![](/files/companies/Verge%20Genomics.png)
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Investors
Connections from
Industry:
Neurodegeneration and aging
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Total Funding:
134120000
Estimated Revenue:
$1M to $10M
Employee Number:
51-100
Founded Date:
2015-01-01
Last Funding Date:
2021-12-16
Headquarters:
San Francisco, California, United States
Investors Number:
26